Ozanimod-d7

CAS: 1306760-87-1

Ref. TR-O880002

Produktinformation

• Name: Ozanimod-d7
• Synonyme: (S)-5-(3-(1-((2-Hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-((propan-2-yl-d7)oxy)benzonitrile, (S)-4-(3-(1-((2-Hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile-d7, 5-[3-[(1S)-2,3-Dihydro-1-[(2-hydroxyethyl)amino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)-benzonitrile-d7
• Marke: TRC
• Beschreibung: Applications Ozanimod-d7 is the labeled analogue of Ozanimod (O880000), which is an agonist that binds to S1P1 and S1P5 receptors. Experiments on rodents revealed that Ozanimod is effective against autoimmune diseases.References Scott, F. L., et al.: Br. J. Pharmacol., 173, 1778 (2016)

Chemische Eigenschaften

• Molekulargewicht: 411.505
• Formel: C₂₃D₇H₁₇N₄O₃
• Farbe/Form: Neat
• InChl: InChI=1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/t20-/m0/s1/i1D3,2D3,14D
• SMILES: [2H]C([2H])([2H])C([2H])(Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N)C([2H])([2H])[2H]